| Application number | Title of the application | Filing Date | Status |
|---|
| 09/416760 | NON-ENDOGENOUS, CONSTITUTIVELY ACTIVATED HUMAN PROTEIN-COUPLED RECEPTORS | Oct 11, 1999 | Abandoned |
| 09/409920 | SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING TEAM | Sep 29, 1999 | Abandoned |
Array
(
[id] => 740618
[patent_doc_number] => 07029861
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'LPS-response gene compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 09/396985
[patent_app_country] => US
[patent_app_date] => 1999-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 41982
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/029/07029861.pdf
[firstpage_image] =>[orig_patent_app_number] => 09396985
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/396985 | LPS-response gene compositions and methods | Sep 14, 1999 | Issued |
| 09/392076 | NOVEL HUMAN CHEMOKINE RECEPTOR-LIKE PTOTEIN | Sep 7, 1999 | Abandoned |
| 09/390938 | NOVEL SECRETED POLYPEPTIDE ZALPHA30 | Sep 6, 1999 | Abandoned |
| 09/382079 | HUMAN RETINOID BINDING PROTEIN | Aug 23, 1999 | Abandoned |
| 09/379246 | SECRETED PROTEINS AND POLYNUCLEOTIDES ENCODING THEM | Aug 22, 1999 | Abandoned |
| 09/377429 | 14274 RECEPTOR, A NOVEL G-PROTEIN COUPLED RECEPTOR RELATED TO THE EDG RECEPTOR FAMILY | Aug 18, 1999 | Abandoned |
| 09/368394 | HUMAN EMR1-LIKE G PROTEIN COUPLED RECEPTOR | Aug 3, 1999 | Abandoned |
Array
(
[id] => 1269629
[patent_doc_number] => 06653086
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Endogenous constitutively activated G protein-coupled orphan receptors'
[patent_app_type] => B1
[patent_app_number] => 09/364425
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 40
[patent_no_of_words] => 31406
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653086.pdf
[firstpage_image] =>[orig_patent_app_number] => 09364425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364425 | Endogenous constitutively activated G protein-coupled orphan receptors | Jul 29, 1999 | Issued |
Array
(
[id] => 4298138
[patent_doc_number] => 06197937
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Modified low density lipoprotein receptor'
[patent_app_type] => 1
[patent_app_number] => 9/352302
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7205
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197937.pdf
[firstpage_image] =>[orig_patent_app_number] => 352302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/352302 | Modified low density lipoprotein receptor | Jul 11, 1999 | Issued |
Array
(
[id] => 1406969
[patent_doc_number] => 06534642
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'Compositions corresponding to a calcium transporter and methods of making and using same'
[patent_app_type] => B1
[patent_app_number] => 09/350457
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 10987
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534642.pdf
[firstpage_image] =>[orig_patent_app_number] => 09350457
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350457 | Compositions corresponding to a calcium transporter and methods of making and using same | Jul 8, 1999 | Issued |
Array
(
[id] => 393812
[patent_doc_number] => 07297504
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-11-20
[patent_title] => 'Methods for identifying agonists and antagonists of human T-type calcium channels'
[patent_app_type] => utility
[patent_app_number] => 09/346794
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8374
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/297/07297504.pdf
[firstpage_image] =>[orig_patent_app_number] => 09346794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/346794 | Methods for identifying agonists and antagonists of human T-type calcium channels | Jul 1, 1999 | Issued |
Array
(
[id] => 532760
[patent_doc_number] => 07179886
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-20
[patent_title] => 'Cloning and identification of the motilin receptor'
[patent_app_type] => utility
[patent_app_number] => 09/719485
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5038
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179886.pdf
[firstpage_image] =>[orig_patent_app_number] => 09719485
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/719485 | Cloning and identification of the motilin receptor | Jun 7, 1999 | Issued |
| 09/326216 | INTERFERON RECEPTOR HKAEF92 | Jun 2, 1999 | Abandoned |
| 09/320864 | LYNX, A NOVEL FAMILY OF RECEPTOR LIGANDS IN THE CENTRAL NERVOUS SYSTEM, CORRESPONDING NUCLEIC ACIDS AND PROTEINS AND USES THEREOF | May 26, 1999 | Abandoned |
Array
(
[id] => 6592836
[patent_doc_number] => 20020042050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'METHODS FOR DIAGNOSING GLAUCOMA AND DISCOVERING ANTI-GLAUCOMA DRUGS'
[patent_app_type] => new
[patent_app_number] => 09/308295
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 756
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042050.pdf
[firstpage_image] =>[orig_patent_app_number] => 09308295
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/308295 | METHODS FOR DIAGNOSING GLAUCOMA AND DISCOVERING ANTI-GLAUCOMA DRUGS | May 16, 1999 | Abandoned |
Array
(
[id] => 4375676
[patent_doc_number] => 06261550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'G-CSF hybrid molecules and pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 9/304186
[patent_app_country] => US
[patent_app_date] => 1999-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 68
[patent_no_of_words] => 34678
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/261/06261550.pdf
[firstpage_image] =>[orig_patent_app_number] => 304186
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/304186 | G-CSF hybrid molecules and pharmaceutical compositions | May 2, 1999 | Issued |
| 09/300327 | PROTEIN PHOSPHATASE 1 BINDING PROTEIN R5 | Apr 26, 1999 | Abandoned |
Array
(
[id] => 1391337
[patent_doc_number] => 06541209
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof'
[patent_app_type] => B1
[patent_app_number] => 09/292072
[patent_app_country] => US
[patent_app_date] => 1999-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 27660
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09292072
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/292072 | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof | Apr 13, 1999 | Issued |
